IRON - NASDAQ

Disc Medicine, Inc.

IRON·NASDAQ

$70.35

-2.3%

HealthcareBiotechnology

Disc Medicine, Inc., a clinical-stage biotechnology company, engages in discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases. It builds a portfolio of therapeutic candidates that address a spectrum of hematologic diseases by targeting fundamental biological pathways of red blood cell biology, primarily heme biosynthesis and iron homeostasis. The company is based in Watertown, Massachusetts.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$2.69B

EPS-6.0100

P/E Ratio-11.71

Earnings Date08/06/2026

iron

Gross Profit

Last Annual Value

-281.00K

3-Year CAGR

5-Year CAGR

10-Year CAGR

Adjust for Inflation

Disc Medicine, Inc. Competitors Analysis of Gross Profit

IRON · NASDAQ

Company	Gross Profit	CAGR 3Y	CAGR 5Y	CAGR 10Y
Disc Medicine, Inc. NASDAQ:IRON	-281.00K	N/A	N/A	N/A
Tarsus Pharmaceuticals, Inc. NASDAQ:TARS	420.68M	198.3%	50.2%	N/A
Celcuity Inc. NASDAQ:CELC	-167.00K	N/A	N/A	N/A
CG Oncology, Inc. Common stock NASDAQ:CGON	-607.00K	N/A	N/A	N/A
Apogee Therapeutics, Inc. NASDAQ:APGE	-1.42M	N/A	N/A	N/A
Adaptive Biotechnologies Corporation NASDAQ:ADPT	205.62M	29.5%	14.4%	N/A
Legend Biotech Corporation NASDAQ:LEGN	622.44M	64.1%	55.3%	N/A
Scholar Rock Holding Corporation NASDAQ:SRRK	-1.66M	N/A	N/A	N/A

Disc Medicine, Inc. Fair Value Envelope

IRON · NASDAQ

Our analysis suggests that IRON has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $70.35, this represents a potential HIDDEN relative to our calculated worth for Disc Medicine, Inc..

HIDDEN

Intrinsic Value

Current Price: $70.35

Related Guides

Blog Categories

Continue your IRON research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.